Atezolizumab Long-Term Overall Survival Picture

John summarizes POWER-010 follow-up showing a possible 10% OS benefit at five years with adjuvant atezolizumab.

Play episode from 05:22

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!